Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine the effect of BIA 9 1067 (5 mg, 15 mg and 50 mg) in steady-state conditions on the levodopa pharmacokinetics of a single dose of immediate-release levodopa/carbidopa 100/25 mg and of a single dose of immediate-release levodopa/benserazide 100/25 mg.
Critère d'inclusion
- Parkinson's disease (PD)